Navigation Links
University of East Anglia makes cancer breakthrough
Date:10/14/2010

Scientists at the University of East Anglia have made an important breakthrough in the way anti-cancer drugs are tested.

A tumour cannot grow to a large size or spread until it has developed its own blood supply and leading research has looked for a way of halting capillary formation to stop tumours taking hold.

But new findings published today in the Journal of Cell Science have shown that scientists testing such treatments may not have been studying exactly what they thought they were.

The research proves that cells are able to switch their genetic profile turning off genes expressed by blood vessel cells and turning on genes specific to lymphatic cells.

This "switch" was previously thought to be impossible and means that scientists may have been researching lymphatic cells, rather than blood vessel cells. It is hoped the discovery will propel the race to find revolutionary new treatments.

Lead author Dr Lin Cooley, said: "It has always been thought that cells could not change from blood to lymphatic vascular cells.

"Other researchers have been doing experiments thinking they were looking at blood vessel cells, when in fact they were looking at lymphatic vascular cells. This breakthrough is important because they have not been studying what they think they have been studying.

"It is a big discovery and will be very important in testing potential anti-cancer drugs."

Researchers used human vein cells in experiments where they form capillaries - the smallest of the body's blood vessels - when cultured in various environments similar to the body.

The human vascular system is made up of two separate circulatory networks the blood and lymphatic vasculature. Blood vessels and lymphatic vessels are structurally similar, but have very different roles, and are made up of two distinct cell types.

Dr Cooley said: "We have discovered that when vein cells form tube structures, they appear to "switch" their genetic profile, turning off genes expressed by blood vessel cells, and turning on genes specific to lymphatic vessels.

"This change can be reversed, and is dependent on the particular environment they are cultured in.

"We have also shown that their identity changes in response to the cell's environment rather than only being specified by signals during early embryonic development".


'/>"/>

Contact: Lisa Horton
l.horton@uea.ac.uk
44-016-035-92226
University of East Anglia
Source:Eurekalert  

Related medicine news :

1. University of Miami receives grant to increase the number of family nurse practitioners
2. University of Colorado gets federal award for Cord Blood Bank
3. UC San Diego partners with Mozambique University to deliver quality health care
4. Better cholesterol drugs may follow Saint Louis University researchers breakthrough
5. U-M Medical School creates joint institute with Peking University
6. University Hospitals Case Medical Centers neuroscience intensive care unit earns Beacon Award
7. Researchers at the University of Granada associate trigger points with shoulder injury
8. The University of Warsaw obtains 3-year site license to Science to provide site-wide access to research institutions in Poland
9. McGill to host inter-university Family Medicine Student Symposium
10. University Hospitals Case Medical Center implements AutoLITT system for treatment of brain tumors
11. Queens University researchers locate impulse control center in brain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
University of East Anglia makes cancer breakthrough
(Date:12/9/2016)... ... December 09, 2016 , ... Flottman ... and outserts. As a means of expanding capabilities Flottman has added a ... to individually code professional inserts (PIs) and patient package inserts (PPIs) that will ...
(Date:12/9/2016)... , ... December 09, 2016 , ... An inventor from ... to safely ride all types of amusement park rides. , The patent-pending SAFETY STRAP ... is easy to use and could be set up in a matter of minutes, ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying ... Va. "I thought that if the nebulizer had a more child-friendly design, then children ... , He developed the patent-pending NEBY to avoid the need to deliver medication via ...
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec 9, 2016 Research ... Screening Market - Forecast to 2021" report to their ... ... of open innovative models in the pharmaceutical and biotechnology industry ... and rising government funding. Emerging markets and growing research activities ...
(Date:12/9/2016)...  RxWiki Inc., a digital health company that powers ... thousands of pharmacies through its Digital Pharmacist SaaS platform, ... "50 on Fire" Award in the Health and Life ... the award as one of Austin,s fastest growing companies," ... RxWiki. "Our platform gives independent retail pharmacies the digital ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, ... AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) ... ,LpxC, for the treatment of bacterial infections including ... been recognized as an attractive antibacterial target for ... lack of suitable chemical starting points has hampered ...
Breaking Medicine Technology: